These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 10600473)

  • 41. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
    Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells.
    Cha MS; Lee MJ; Je GH; Kwak JY
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1061-6. PubMed ID: 11352660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
    Dougher M; Terman BI
    Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.
    Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J
    Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
    Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of human thyroid endothelial cells.
    Patel VA; Logan A; Watkinson JC; Uz-Zaman S; Sheppard MC; Ramsden JD; Eggo MC
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E168-76. PubMed ID: 12388152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells.
    Hewett PW; Murray JC
    Biochem Biophys Res Commun; 1996 Apr; 221(3):697-702. PubMed ID: 8630024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
    Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N
    EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src.
    He H; Venema VJ; Gu X; Venema RC; Marrero MB; Caldwell RB
    J Biol Chem; 1999 Aug; 274(35):25130-5. PubMed ID: 10455194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells.
    Tran J; Rak J; Sheehan C; Saibil SD; LaCasse E; Korneluk RG; Kerbel RS
    Biochem Biophys Res Commun; 1999 Nov; 264(3):781-8. PubMed ID: 10544009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia.
    Brockelsby J; Hayman R; Ahmed A; Warren A; Johnson I; Baker P
    Lab Invest; 1999 Sep; 79(9):1101-11. PubMed ID: 10496528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors.
    Iruela-Arispe ML; Rodriguez-Manzaneque JC; Abu-Jawdeh G
    Microcirculation; 1999 Jun; 6(2):127-40. PubMed ID: 10466115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
    Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E
    Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
    Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
    Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
    Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
    Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.